Brief: Sana Biotechnology Inc - QTRLY Loss Per Share $0.39
Sana Biotechnology Inc SANA.O :
* SANA BIOTECHNOLOGY REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS
AND BUSINESS UPDATES
* EXPECT CASH RUNWAY INTO 2025
* EXPECT TO FILE INDS THIS YEAR FOR SC291 AND SG295
* Q2 2022 CASH POSITION OF $579.6 MILLION
* QTRLY LOSS PER SHARE $0.39
* Q2 EARNINGS PER SHARE VIEW $-0.51 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX8DknTw
Further company coverage: SANA.O
Recent news on Sana Biotechnology
See all newsSana Biotechnology Inc reports results for the quarter ended June 30 - Earnings Summary
Sana Biotechnology Q2 adjusted loss narrows, beats estimates
Brief: Sana Biotechnology Q2 Adjusted EPS USD -0.13 Vs. IBES Estimate USD -0.15
Sana Biotechnology posts Q1 adjusted loss narrower than expected, extends cash runway
Brief: Sana Biotechnology Q1 Adjusted EPS USD -0.14 Vs. IBES Estimate USD -0.17